Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011

S A Uldum1, J M Bangsborg, B Gahrn-Hansen

  • 1Statens Serum Institut, Copenhagen, Denmark. su@ssi.dk

Insights

Denmark saw two large Mycoplasma pneumoniae infection waves in 2010 and 2011. Despite high macrolide antibiotic use, Mycoplasma pneumoniae resistance remained low.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Epidemiology

Background:

  • Mycoplasma pneumoniae is a common cause of respiratory infections.
  • Understanding infection dynamics and antimicrobial resistance is crucial for public health.
  • Denmark experienced significant Mycoplasma pneumoniae outbreaks in 2010 and 2011.

Purpose of the Study:

  • To analyze the epidemiology of two Mycoplasma pneumoniae infection waves in Denmark.
  • To investigate the relationship between macrolide consumption and macrolide resistance in M. pneumoniae during these outbreaks.

Main Methods:

  • Retrospective analysis of national surveillance data for Mycoplasma pneumoniae infections.
  • Monitoring of macrolide consumption and macrolide resistance levels in M. pneumoniae isolates.
  • Comparison of infection wave size and resistance trends.

Main Results:

  • Two distinct nationwide waves of Mycoplasma pneumoniae infection occurred in autumn 2010 and early winter 2011.
  • The proportion of positive results was similar for both waves, suggesting comparable sizes.
  • Macrolide consumption increased during the epidemics, but macrolide resistance in M. pneumoniae remained consistently low (1% to 3%).

Conclusions:

  • Mycoplasma pneumoniae outbreaks can occur as distinct waves affecting entire countries.
  • High macrolide consumption during M. pneumoniae epidemics did not lead to increased resistance in Denmark.
  • Sustained low levels of macrolide resistance in M. pneumoniae are a key finding in Denmark.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...